November 10, 2016 / 11:17 AM / 9 months ago

BRIEF-Knight Therapeutics qtrly diluted EPS C$0.04

Nov 10 (Reuters) - Knight Therapeutics Inc

* Qtrly diluted earnings per share $0.04

* All figures in c$

* Knight reports third quarter 2016 results Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below